Investment Summary |
|
|---|---|
| Date | 2013-12-01 |
| Target | Fabric Genomics |
| Sector | Information Technology |
| Investor(s) | Bay City Capital |
| Deal Type | Venture |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 74 of 75 |
| Sector: Information Technology M&A | 6 of 6 |
| Type: Venture M&A Deals | 49 of 49 |
| State: California M&A | 41 of 41 |
| Country: United States M&A | 71 of 72 |
| Year: 2013 M&A | 10 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-29 |
Cymabay Therapeutics
Newark, California, United States Cymabay Therapeutics is a clinical-stage bio-pharmaceutical company developing breakthrough therapies addressing unmet medical needs. Cymabay Therapeutics was founded in 1988 and is based in Newark, California. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-11 |
Cadence Pharmaceuticals
San Diego, California, United States Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. |
Sell | $1.3B |
